These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13167118)

  • 1. Dicumarol and plasma antithrombin activity.
    IVANOVIC N; JOHNSON JF; OLWIN JH; SEEGERS WH
    Proc Soc Exp Biol Med; 1954 Mar; 85(3):496-500. PubMed ID: 13167118
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.
    MAYER GA; CONNELL WF
    J Am Med Assoc; 1956 Jun; 161(9):806-11. PubMed ID: 13319011
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the coagulation disturbance in human plasma following the ingestion of dicumarol.
    BARKHAN P
    S Afr J Med Sci; 1954 Dec; 19(4):141-6. PubMed ID: 13255993
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of dicumarol on certain factors of blood coagulation.
    SHANBERGE JN
    J Lab Clin Med; 1956 Aug; 48(2):218-22. PubMed ID: 13346188
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation time of the blood in lusteroid tubes; a study of patients receiving dicumarol.
    KADISH AH
    Am Heart J; 1947 Aug; 34(2):225-9. PubMed ID: 20255266
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments.
    WESSLER S
    J Clin Invest; 1953 Jul; 32(7):650-4. PubMed ID: 13069611
    [No Abstract]   [Full Text] [Related]  

  • 8. The regulation of dicumarol dosage by special venous clotting technics.
    MACRAE LD
    Am Pract Dig Treat; 1956 Jan; 7(1):38-43. PubMed ID: 13275654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of total blood coagulability in control of dicumarol therapy of thrombophlebitis].
    COTTAFAVI M
    Minerva Ginecol; 1955 Dec; 7(24):853-8. PubMed ID: 13288023
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis.
    WESSLER S; MORRIS LE
    Circulation; 1955 Oct; 12(4):553-6. PubMed ID: 13261307
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 12. Over-all coagulability in patients receiving dicumarol therapy with emphasis on acute myocardial infarction.
    ROSENTHAL RL
    J Lab Clin Med; 1956 Apr; 47(4):611-22. PubMed ID: 13307096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Control of dicoumarin effect on blood coagulation].
    THIES HA
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1952-1953; 273():320-2. PubMed ID: 13045631
    [No Abstract]   [Full Text] [Related]  

  • 14. Dicumarol therapy. Some effects on platelets and their relationship to clotting tests.
    MURPHY EA; MUSTARD JF
    Circ Res; 1960 Nov; 8():1187-99. PubMed ID: 13726966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of venous thrombosis with dicoumarol ethyl acetate regulated daily according to Quick's control time and plasma clotting-time in the presence of one unit of heparin].
    IZARN P
    Presse Med (1893); 1953 Feb; 61(8):146-8. PubMed ID: 13055744
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on ethylidene dicoumarin as an anticoagulant, with special reference to puerperal patients.
    ROSE WM; KRIEGER VI
    Med J Aust; 1951 Dec; 2(24):813-7. PubMed ID: 14909857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of coagulation time in dicumarol therapy].
    DELLA SANTA R; FALLER R
    Schweiz Med Wochenschr; 1951 Dec; 81(50):1242-4. PubMed ID: 14913081
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 19. Action of 3,3' methylenebis (4-hydroxycoumarin) (dicumarol) on thromboplastic activity of rabbit brain.
    STEFANINI M; BLANCHAER MC
    Proc Soc Exp Biol Med; 1947 Jan; 64(1):47-50. PubMed ID: 20285458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Theory and practice of blood coagulation. III. Therapeutic use of heparine and dicumarol].
    OSTEN W
    Dtsch Med J; 1952 May; 3(9-10):209-12. PubMed ID: 14954830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.